Eisai
4523.T
#2143
Rank
S$11.51 B
Marketcap
S$40.79
Share price
3.73%
Change (1 day)
9.79%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

Eisai (4523.T) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : S$4.22 Billion

According to Eisai's latest financial reports the company's total liabilities are S$4.22 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Eisai - Total liabilities on balance sheet (from 2009 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-03-31S$4.40 B-15.24%
2022-03-31S$5.19 B17.6%
2021-03-31S$4.41 B-6.68%
2020-03-31S$4.73 B-7.57%
2019-03-31S$5.11 B-4.58%
2018-03-31S$5.36 B0.27%
2017-03-31S$5.34 B12.26%
2016-03-31S$4.76 B-7.81%
2015-03-31S$5.16 B-4.9%
2014-03-31S$5.43 B-19.97%
2013-03-31S$6.79 B-22.95%
2012-03-31S$8.81 B-8.54%
2011-03-31S$9.63 B-5.17%
2010-03-31S$10.16 B-7.41%
2009-03-31S$10.97 B18.57%
2008-03-31S$9.25 B213.19%
2007-03-31S$2.95 B-6.2%
2006-03-31S$3.15 B0.23%
2005-03-31S$3.14 B-0.11%
2004-03-31S$3.14 B3.37%
2003-03-31S$3.04 B17.96%
2002-03-31S$2.58 B-11.54%
2001-03-31S$2.91 B